Plasmid
It has a clinical plasmid production workshop and independently develops a clinical plasmid production process with good product stability and linear amplification.
Lentivirus
It can realize fully enclosed and fully automated production process, and the independent production process can achieve a single batch of lentivirus total titer of 1 × 10¹².
Cell Development
It has the ability to independently and large-scale production of various immune cells such as CART, UCART, and CAR-NK. The self-developed PRIMECAR platform can ensure that patients can complete the entire process from blood collection to reinfusion within 7 days.
Quality Control
Established a complete quality control chain, and realized independent quality research capabilities from four aspects: cell characteristic analysis, functional analysis, purity analysis and safety analysis; independently developed lentivirus RCL detection, and cooperated with drug control institutes to detect; It has achieved independent .
